Who owns Allergosan?
Allergosan is owned by Sopharma (Bulgaria, BSE Sofia: SFA).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Key facts
- Current owner
- Sopharma AD reported
- Owned since
- Not recorded
- Previous owner
- None recorded
- Owner HQ
- 🇧🇬 Bulgaria, Sofia
- Origin
- 🇧🇬 Bulgaria
- Category
- Consumer health › Over-the-counter medicine › Cold
- Parent ticker
- BSE Sofia: SFA WSE: SPH
- Last verified
- · 1 sources
About Allergosan
Allergosan is the anti-allergy brand in Sopharma's consumer healthcare range, sold as a 25 mg coated tablet, a 10 mg per gram cream and a 1 gram per 100 gram ointment. Sopharma renewed the Georgian authorisation for the ointment in the first half of 2026 and submitted the tablet and the cream for registration in Belarus. In Bulgaria it is sold under the local spelling Allergozan.
Ownership timeline of Allergosan
Where Allergosan sits in Sopharma
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Sopharma ownership tree →
Other brands owned by Sopharma in consumer health
Latest news about Allergosan
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Allergosan?
The parent company of Allergosan is Sopharma, a publicly listed company headquartered in Bulgaria.
Is Allergosan Bulgarian?
Yes. Allergosan originated in Bulgaria and its owner, Sopharma, is also headquartered in Bulgaria.
Is Allergosan still owned by Sopharma?
Yes. As of 20 September 2026, Allergosan is still owned by Sopharma. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sopharma Group consolidated management report for the first half of 2026 — Sopharma AD, Stock exchange filing, published 30 June 2026; retrieved 20 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.